Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FY 2005 Medicare Inpatient Payment Rule In Brief

This article was originally published in The Gray Sheet

Executive Summary

Implantable defibrillator payments: CMS appears to be waiting to determine ICD payments until it issues a decision expanding national coverage based on the SCD-HeFT trial population, expected by year-end. The agency came under heavy fire from industry and professional societies for soliciting comments in the inpatient prospective payment system proposed rule on ways to encourage less expensive use of ICDs when clinically appropriate (1"The Gray Sheet" July 5, 2004, p. 8). The final rule does not discuss stakeholder comments or a final policy...

You may also be interested in...



Is CMS Charitably Inclined Toward DePuy Spine Disc? Other Payors Take Heed

Johnson & Johnson/DePuy will submit hospital claims data to CMS in an effort to convince the agency that the Charité artificial spine disc yields better outcomes for Medicare patients when compared with fusion

Is CMS Charitably Inclined Toward DePuy Spine Disc? Other Payors Take Heed

Johnson & Johnson/DePuy will submit hospital claims data to CMS in an effort to convince the agency that the Charité artificial spine disc yields better outcomes for Medicare patients when compared with fusion

Reimbursement Woes Could Impact Charité Sales – Spine Surgeon Blumenthal

Third-party payor reluctance to reimburse for Johnson & Johnson/DePuy's Charité total artificial disc could hinder its adoption, the device's principal investigator, Scott Blumenthal, MD, Texas Back Institute, contends

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel